Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 166 AL 180

Editorial: Multi-target Drug Discovery - Part II

Chen JN.

Curr Top Med Chem. 2017 Nov 20;17(28):3081-3083. doi: 10.2174/156802661728171120143727.

The past, present, and future of disease-modifying therapies for Alzheimer's disease

Suzuki K, Iwata A, Iwatsubo T.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(10):757-771. doi: 10.2183/pjab.93.048.

Rho GTPases as therapeutic targets in Alzheimer's disease

Aguilar BJ, Zhu Y, Lu Q.

Alzheimers Res Ther. 2017 Dec 15;9(1):97. doi: 10.1186/s13195-017-0320-4.

Targeting Neuroinflammation to Treat Alzheimer's Disease

Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzériat K, Dansokho C, Dierkes T, Gelders G, Heneka MT, Hoeijmakers L, Hoffmann A, Iaccarino L, Jahnert S, Kuhbandner K, Landreth G, Lonnemann N, Löschmann PA, McManus RM, Paulus A, Reemst K, Sanchez-Caro JM, Tiberi A, Van der Perren A, Vautheny A, Venegas C, Webers A, Weydt P, Wijasa TS, Xiang X, Yang Y.

CNS Drugs. 2017 Dec;31(12):1057-1082. doi: 10.1007/s40263-017-0483-3.

Biochemical Properties and Neuroprotective Effects of Compounds in Various Species of Berries

Kelly E, Vyas P, Weber JT.

Molecules. 2017 Dec 22;23(1):26. doi: 10.3390/molecules23010026.

Nasal steroids as a possible treatment for Alzheimer's disease

Lehrer S, Rheinstein PH.

Discov Med. 2017 Oct;24(132):147-152.

Drug discovery, development and delivery in Alzheimer's disease

Brambilla D.

Pharm Res. 2017 Dec 29;35(1):3. doi: 10.1007/s11095-017-2329-6.

Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules

Umar T, Hoda N.

Curr Top Med Chem. 2017;17(31):3370-3389. doi: 10.2174/1568026618666180112161024.

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

Rampa A, Gobbi S, Concetta Di Martino RM, Belluti F, Bisi A.

Curr Top Med Chem. 2017;17(31):3361-3369. doi: 10.2174/1568026618666180112161406.

Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease

Ismaili L, do Carmo Carreiras M.

Curr Top Med Chem. 2017;17(31):3319-3327. doi: 10.2174/1568026618666180112155424.

New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines

Oset-Gasque MJ, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3349-3360. doi: 10.2174/1568026618666180112155928.

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

Romero A, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3328-3335. doi: 10.2174/1568026618666180112155639.

Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics

Chakraborty S.

Curr Top Med Chem. 2017;17(31):3336-3348. doi: 10.2174/1568026618666180116122921.

Objective and Subjective Cognitive Problems among Caregivers and Matched Non-caregivers

Vitaliano PP, Ustundag O, Borson S.

Gerontologist. 2017 Aug 1;57(4):637-647. doi: 10.1093/geront/gnv690.

Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry

Garcia-Ptacek S, Modéer IN, Kåreholt I, Fereshtehnejad SM, Farahmand B, Religa D, Eriksdotter M.

Age Ageing. 2017 Mar 1;46(2):314-319. doi: 10.1093/ageing/afw189.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias